Sign in

CIK 0001787306

  • Large accelerated filer

Arcutis Biotherapeutics, Inc.

Sign in to watch
Ticker
ARQT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
812974255
Phone
+1 805-418-5006
Business address
3027 TOWNSGATE ROAD, SUITE 300, WESTLAKE VILLAGE, CA, 91361
Former names
Arcutis, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$3,253,826
in 9 filings, $2.1M under 10b5-1 plans

Net −$3,253,826. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-05-31 Leonard Keith R Director Grant or award · Stock Option (right to buy) +12,220 12,220
2023-05-31 Krishnamohan Neha Director Grant or award +4,375 5,607
2023-05-31 Krishnamohan Neha Director Grant or award · Stock Option (right to buy) +12,220 12,220
2023-05-31 Welgus Howard G. Director Grant or award +4,375 170,200
2023-05-31 Welgus Howard G. Director Grant or award · Stock Option (right to buy) +12,220 12,220
2023-05-27 Matsuda Masaru Grant or award +4,875 43,976
2023-04-17 Welgus Howard G. Director Exercise or conversion 10b5-1 +8,500 $1.68 $14K 174,325
2023-04-17 Welgus Howard G. Director Sale 10b5-1 −8,500 $13.97 $119K 165,825
2023-04-17 Welgus Howard G. Director Exercise or conversion · Stock Option (right to buy) 10b5-1 −8,500 6,458
2023-04-06 Welgus Howard G. Director Exercise or conversion 10b5-1 +8,500 $1.68 $14K 174,325
2023-04-06 Welgus Howard G. Director Sale 10b5-1 −8,500 $12.01 $102K 165,825
2023-04-06 Welgus Howard G. Director Exercise or conversion · Stock Option (right to buy) 10b5-1 −8,500 14,958
2023-03-06 Watanabe Todd Franklin Director Sale −2,435 $15.26 $37K 366,657
2023-03-06 Burrows Scott L Chief Financial Officer Sale −291 $15.26 $4K 59,115
2023-03-06 Burnett Patrick Sale −851 $15.26 $13K 59,962
2023-03-06 Turney Patricia A. SVP, Operations Sale −831 $15.26 $13K 62,862
2023-03-06 OSBORNE DAVID W Chief Technical Officer Sale −690 $15.26 $11K 268,854
2023-03-06 Lock Kenneth A. Chief Commercial Officer Sale −831 $15.26 $13K 63,429
2023-03-02 Watanabe Todd Franklin Director Grant or award +87,500 456,592
2023-03-02 Watanabe Todd Franklin Director Grant or award · Stock Option (right to buy) +232,000 232,000

Page 24 of 35 · 689 trades